Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Role of structural MRI in Alzheimer's disease | Synapse

August 1, 2010Open Access

Role of structural MRI in Alzheimer's disease

PVPrashanthi VemuriKarlsruhe Institute of Technology

Clifford R. JackMayo Clinic in Arizona

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Vemuri et al. (Sun,) studied this question.

synapsesocial.com/papers/6a63f319aab374d588f2f05e https://doi.org/https://doi.org/10.1186/alzrt47